HAPLN2 and neoplasm: Silencing of genes involved in cell adhesion may lead to tumor aggressiveness and tumor progression [9], as was shown for CD97, CTNNA1, DLC1, and HAPLN2 genes in which hypermethylation was associated with poorer survival of patients with ovarian cancer [17].